Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort study
Omer Denizhan Tatar, Levent Kılıç, Umut Kalyoncu, Ali Ihsan Ertenli · 2026
Read Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort study by Omer Denizhan Tatar, Levent Kılıç, Umut Kalyoncu, Ali Ihsan Ertenli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13219159.txt.
Description
Omer Denizhan Tatar and co-authors ask whether body weight at the start of rheumatoid arthritis therapy predicts early recovery in a 2026 cohort study. Obesity is common in this disease, and clinicians suspect it blunts response, but data at the moment of first starting a biologic or targeted drug were incomplete. The study followed patients who began a first advanced therapy between 2013 and 2020.
Of 574 patients with body mass data, about forty-one percent had obesity. Remission at nine months was evaluable in 258 patients and occurred less often in those with obesity than in leaner groups, although the adjusted association hovered at the edge of significance. Functional recovery on a disability questionnaire told a story: higher body mass index was tied to less complete recovery, softening when blood pressure and diabetes entered the model. The authors frame the findings as prognostic rather than causal, useful for setting expectations at start.
Catalog record
| CREATOR | Omer Denizhan Tatar, Levent Kılıç, Umut Kalyoncu, Ali Ihsan Ertenli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |